OmniAb (OABI) Capital Expenditures (2022 - 2026)

OmniAb's (OABI) quarterly Capital Expenditures came in at $167000.0 in Q1 2026, down 20.1% year-on-year from $209000.0 in Q1 2025, and down 84.49% on a QoQ basis from $1.1 million in Q4 2025.

OmniAb (OABI) Capital Expenditures (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of Capital Expenditures data on file, last reported at $167000.0 in Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 20.1% year-over-year to $167000.0 in Q1 2026; TTM through Mar 2026 was $523000.0, a 67.72% decrease from a year earlier, with the FY2025 full-year figure at $565000.0, down 69.87% from the prior year.
  • Capital Expenditures for Q1 2026 stood at $167000.0, down from $1.1 million in the prior quarter.
  • Over the last five years, Capital Expenditures for OABI reached as high as $2.5 million in Q4 2022 and fell as low as -$5.4 million in Q3 2022.
  • Historically, Capital Expenditures has averaged $238941.2 across 5 years, with a median of $317000.0 in 2023.
  • On a YoY basis, Capital Expenditures climbed as much as 537.74% in 2024 and fell as far as 2810.39% in 2024.
  • Year by year, Capital Expenditures stood at $2.5 million in 2022, then tumbled by 79.04% to $533000.0 in 2023, then soared by 357.6% to $2.4 million in 2024, then sank by 55.84% to $1.1 million in 2025, then tumbled by 84.49% to $167000.0 in 2026.
  • Per Business Quant data, the three most recent Capital Expenditures figures were $167000.0 in Q1 2026, $1.1 million in Q4 2025, and -$886000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 43.25 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 786,000.00
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn 167,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 167,000.00
Mar 31, 2026 167,000.00
Dec 31, 2025 1.08 Mn
Dec 31, 2025 1.08 Mn
Sep 30, 2025 -886,000.00
Sep 30, 2025 -886,000.00
Jun 30, 2025 165,000.00
Jun 30, 2025 165,000.00
Mar 31, 2025 209,000.00
Mar 31, 2025 209,000.00
Dec 31, 2024 2.44 Mn
Dec 31, 2024 2.44 Mn
Sep 30, 2024 -2.24 Mn
Sep 30, 2024 -2.24 Mn
Jun 30, 2024 1.21 Mn
Jun 30, 2024 1.21 Mn
Mar 31, 2024 464,000.00
Mar 31, 2024 464,000.00
Dec 31, 2023 533,000.00
Dec 31, 2023 533,000.00